Skip to main content
. 2018 Aug 31;68(5):803–809. doi: 10.1093/cid/ciy554

Table 3.

Adverse Events Occurring ≥5% of Subjects in Any Treatment Group

MedDRA Preferred Term TOL-463 Vaginal Gel (n = 55) TOL-463 Vaginal Insert (n = 49) All Subjects (n = 104) Treatment Related Only
Headache 1 (2) 4 (8) 5 (5) 2 (2)
Vulvovaginal burning sensation 5 (9) 5 (10) 10 (10) 10 (10)
Vulvovaginal pruritus 4 (7) 3 (6) 7 (7) 7 (7)

Data are presented as No. (%).

Abbreviation: MedDRA, Medical Dictionary for Regulatory Activities.